neurokinin-1 receptor antagonist
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for neurokinin-1 receptor antagonist, covering 2019-07-02 to 2020-07-13. Get the full timeline:
Most recent: Clinical Trial Update: To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients [Phase 3]